Fortress Biotech, Inc. Inventory, Gross
Fortress Biotech, Inc. (FBIO) had Inventory, Gross of $10.75 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:InventoryGross · last filed 2026-08-13
- 2026-06-30: Inventory, Gross $10.75M.
- 2026-03-31: Inventory, Gross $11.67M.
- 2025-12-31: Inventory, Gross $10.62M.
- 2025-09-30: Inventory, Gross $12.58M.
| Period end | Inventory, Gross |
|---|---|
| 2026-06-30 | $10.75M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $11.67M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $10.62M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $12.58M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $13.56M 10-Q · filed 2025-08-14 |
| 2024-12-31 | $14.94M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |